A leading radiology expert in the United States, Sim Hoffman is naturally fascinated by the potential of molecular imaging. In simple terms, the premise of the method is to one day be able to successfully identify local biological processes with the help of medical imaging. The body has an inflammation somewhere that the radiologist wants to see? The doctor wants to understand certain metabolic processes? The answer to these medical conundrums can be molecular imaging.
We Are Not Actually That Far
Molecular imaging is more than a concept. In fact, it is already used in some form, mainly in the oncology field. Pharmaceutical companies are basing some of their medical solutions on this technology. There are ongoing clinical trials that could change the process of imaging evaluation, as we know it.
Cardiovascular Molecular Imaging
What’s available in the field of oncology, is not much more than a mere concept when it comes to cardiovascular imaging. With that said, the metabolic imaging of the myocardium (heart muscle) is already available. It involves the injection of a contrast material that contains glucose into the arteries of the patient. Then the imaging technology shows the glucose uptake of the myocardium. Even some inflammatory processes can be detected that way, but the technology is simply not refined yet to really work as a wide-spread molecular imaging solution.
Fighting the good fight in the last several decades, Sim Hoffman fully understands the impact that a readily available, diverse molecular imaging technology could mean to the field of medicine, and to science in general.